Early Access to Merck’s New Integrase Inhibitor
HIV/AIDS Clinical Care AIDS Watch
Free Article
Merck has announced an expanded access research program to provide early access to MK-0518, its investigational integrase inhibitor. The program, called EARMRK, is for treatment-experienced . . .
New Statistics on AIDS Deaths in India
HIV/AIDS Clinical Care AIDS Watch
Subscription Required
HIV Prevalence Stabilizing in South Africa
HIV/AIDS Clinical Care AIDS Watch
Subscription Required
Syphilis on the Rise
HIV/AIDS Clinical Care AIDS Watch
Subscription Required
Save the Date: 14th Retrovirus Conference
HIV/AIDS Clinical Care AIDS Watch
Subscription Required
South Africa Has Largest Antiretroviral Program
HIV/AIDS Clinical Care AIDS Watch
Subscription Required
According to government officials, South Africa now has the largest antiretroviral treatment program in the world, with more than 210,000 HIV-infected individuals on antiretroviral therapy.
Little Sign of AIDS Fatigue in the U.S.
HIV/AIDS Clinical Care AIDS Watch
Subscription Required
About 60% of Americans feel that the U.S. has a responsibility — and should be spending more money — to fight HIV/AIDS in developing countries. . . .
Global Shortage of Healthcare Workers
HIV/AIDS Clinical Care AIDS Watch
Subscription Required
Fifty-seven nations currently face a severe shortage of healthcare workers. The problem is most dire in sub-Saharan Africa, which has more than 60% of the . . .
dD4FC Development Discontinued
HIV/AIDS Clinical Care AIDS Watch
Free Article
On April 3, 2006, Incyte Corporation halted development of the investigational NRTI, dD4FC (Reverset), because of safety concerns. In a previous phase IIb trial, investigators . . .
Prevalence of Multidrug-Resistant TB Rising
HIV/AIDS Clinical Care AIDS Watch
Subscription Required
Multidrug-resistant tuberculosis (TB) is becoming increasingly common, according to a CDC/WHO survey of 25 TB laboratories on six continents. Seven percent of TB isolates were . . .
